Antipsychotics in the Treatment of Children and Adolescents with Anorexia Nervosa: A Systematic Review
- PMID: 36551922
- PMCID: PMC9775317
- DOI: 10.3390/biomedicines10123167
Antipsychotics in the Treatment of Children and Adolescents with Anorexia Nervosa: A Systematic Review
Abstract
Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics in this population. A total of 499 studies were identified with the initial search, and 28 of these studies were selected regarding the use of olanzapine (n = 13), risperidone (n = 4), aripiprazole (n = 3), chlorpromazine (n = 3), pimozide (n = 1) clotiapine (n = 1) and multiple antipsychotics (n = 3) in these patients. Overall, major side effects were reported infrequently; improvements in psychopathology and weight measures have been suggested in the majority of the considered studies. Nonetheless, the lack of RCT or good-quality studies strongly limits the generalizability of results in clinical practice.
Keywords: anorexia nervosa; antipsychotics; children and adolescents; feeding and eating disorders.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- American Psychiatric Association . In: Diagnostic and Statistical Manual of Mental Disorders: DMS-5. 5th ed. Cortina R., editor. American Psychiatric Association; Arlington, VA, USA: 2013.
-
- Pruccoli J., De Rosa M., Chiasso L., Perrone A., Parmeggiani A. The use of TikTok among children and adolescents with Eating Disorders: Experience in a third-level public Italian center during the SARS-CoV-2 pandemic. Ital. J. Pediatr. 2022;48:138. doi: 10.1186/s13052-022-01308-4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
